# Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

> **NCT03998657** · NA · ACTIVE_NOT_RECRUITING · sponsor: **InSightec** · enrollment: 14 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Exablate Prostate Treatment

## Key facts

- **NCT ID:** NCT03998657
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-19
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998657, "Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03998657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*